Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald L Hamilton

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Journal of Alzheimer'S Disease : JAD|November 26, 2013
Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosisPatrick S Murray, Caitlin M Kirkwood, Megan C Gray, et al.
Journal of Neuropathology and Experimental Neurology|May 17, 2005
INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinomaAlexander R Judkins, Peter C Burger, Ronald L Hamilton, et al.
Scientific Reports|February 2, 2019
Identification of recurrent fusion genes across multiple cancer typesYan-Ping Yu, Peng Liu, Joel Nelson, et al.
Neuro-Oncology|February 23, 2011
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology GroupKenneth J Cohen, Ian F Pollack, Tianni Zhou, et al.
Journal of Neuro-Oncology|July 8, 2010
Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology GroupIan F Pollack, Ronald L Hamilton, Peter C Burger, et al.
Neuro-Oncology|December 19, 2015
Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumorsMarina N Nikiforova, Abigail I Wald, Melissa A Melan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2009
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1Ryo Ueda, Gary Kohanbash, Kotaro Sasaki, et al.
Neuro-Oncology|March 24, 2016
Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 studyRegina I Jakacki, Kenneth J Cohen, Allen Buxton, et al.
Acta Neuropathologica|January 25, 2012
Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical studyMilos D Ikonomovic, Eric E Abrahamson, Julie C Price, et al.
Acta Neuropathologica|July 16, 2008
Evaluation of alpha-synuclein immunohistochemical methods used by invited expertsThomas G Beach, Charles L White, Ronald L Hamilton, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Journal of Alzheimer'S Disease : JAD|November 26, 2013
Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosisPatrick S Murray, Caitlin M Kirkwood, Megan C Gray, et al.
Journal of Neuropathology and Experimental Neurology|May 17, 2005
INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinomaAlexander R Judkins, Peter C Burger, Ronald L Hamilton, et al.
Scientific Reports|February 2, 2019
Identification of recurrent fusion genes across multiple cancer typesYan-Ping Yu, Peng Liu, Joel Nelson, et al.
Neuro-Oncology|February 23, 2011
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology GroupKenneth J Cohen, Ian F Pollack, Tianni Zhou, et al.
Journal of Neuro-Oncology|July 8, 2010
Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology GroupIan F Pollack, Ronald L Hamilton, Peter C Burger, et al.
Neuro-Oncology|December 19, 2015
Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumorsMarina N Nikiforova, Abigail I Wald, Melissa A Melan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2009
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1Ryo Ueda, Gary Kohanbash, Kotaro Sasaki, et al.
Neuro-Oncology|March 24, 2016
Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 studyRegina I Jakacki, Kenneth J Cohen, Allen Buxton, et al.
Acta Neuropathologica|January 25, 2012
Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical studyMilos D Ikonomovic, Eric E Abrahamson, Julie C Price, et al.
Acta Neuropathologica|July 16, 2008
Evaluation of alpha-synuclein immunohistochemical methods used by invited expertsThomas G Beach, Charles L White, Ronald L Hamilton, et al.
Pageof 15